China's Top Departments: Psychiatry at Shanghai Mental Health Center

If you're facing depression, anxiety, obsessive-compulsive disorder, schizophrenia, or cognitive decline, Shanghai Mental Health Center (SMHC) is China's leading destination for comprehensive, evidence-based psychiatric care. Founded in 1935 and now affiliated with Shanghai Jiao Tong University School of Medicine, SMHC is ranked #2 in Psychiatry nationally by Fudan Hospital Rankings and serves as the main body of China's National Center for Mental Health Disorders (designated 2022, one of only three such centers in China and the sole one in Shanghai).

The numbers reflect SMHC's scale and reputation: over 320,000 annual outpatient and emergency visits (60% of Shanghai's total psychiatric visits), approximately 4,000 annual inpatient admissions, and 2,141 operating beds. Patients come from across China and over 20 countries and regions worldwide.

At ChinaMed Select, we've helped international patients access SMHC's expertise for conditions ranging from treatment-resistant depression to OCD to early-stage Alzheimer's disease. Here's what you need to know.

National Standing & Recognition

SMHC holds multiple prestigious designations that reflect its national leadership:

• Fudan Hospital Rankings: #2 in Psychiatry nationally, #1 in East China
• National Center for Mental Health Disorders (2022) — one of only three in China
• National Center for Psychiatric Quality Control (under preparation)
• National Regional Medical Center (output hospital)
• WHO Collaborating Center for Mental Health Research and Training in Shanghai
• Shanghai Public Hospital High-Quality Development Pilot Unit

Comprehensive Clinical Specialties

SMHC operates a complete lifespan approach to mental health with dedicated centers for every major psychiatric condition:

National Clinical Key Specialties (4)

1. Psychiatry — General adult psychiatry
2. Severe Mental Disorders — Schizophrenia, bipolar disorder, treatment-resistant psychosis
3. Psychiatric Rehabilitation — Recovery-focused programs
4. Integrated Chinese-Western Medicine — Combining traditional and modern approaches

Shanghai Municipal Key Disciplines

• Shanghai Clinical Medical Center for Mental Disorders
• Geriatric Psychiatry — China's earliest geriatric psychiatry sub-specialty (est. 1982)
• Preventive Psychiatry

Sub-Specialty System

SMHC's comprehensive diagnosis and treatment centers cover the full lifespan:

• Geriatric Mental Disorders: Alzheimer's disease, vascular dementia, late-life depression
• Mood Disorders: Depression, bipolar disorder, treatment-resistant depression
• Psychosomatic Disorders: Physical symptoms with psychological origins
• Addiction Disorders: Alcohol, tobacco, drugs, behavioral addictions
• Child & Adolescent Mental Disorders: ADHD, autism spectrum, behavioral disorders, anxiety
• Psychiatric Emergencies: Acute crisis intervention
• Psychotic Disorders: Schizophrenia, schizoaffective disorder
• Neuromodulation: Advanced brain stimulation therapies
• Mental Health Management: Prevention and early intervention
• Psychiatric Rehabilitation: Functional recovery programs
• Traditional Chinese Medicine for Mental Disorders: Integrated approaches

Clinical Psychology Department

The Clinical Psychology Department operates four core sub-specialty centers:

1. Obsessive-Compulsive Disorder Center (established 1997) — One of China's first dedicated OCD treatment centers
2. Anxiety Disorders Center — Panic disorder, generalized anxiety, social anxiety, phobias
3. Eating Disorders Center — Anorexia, bulimia, binge eating disorder
4. Sleep Disorders Center — Insomnia, sleep apnea, circadian rhythm disorders

Core Treatment Approach: "Quadruple Therapy"

SMHC employs an integrated "Quadruple Therapy" model combining four complementary modalities:

1. Pharmacotherapy

Precision integrated Chinese-Western medicine approaches, including:

• Evidence-based psychotropic medication management
• Pharmacogenomic testing for personalized medication selection
• Integration of traditional Chinese herbal medicine where appropriate
• Participation in national clinical trials for novel compounds

2. Neuromodulation

SMHC is a national leader in advanced brain stimulation therapies:

• rTMS (repetitive Transcranial Magnetic Stimulation) for depression, OCD, auditory hallucinations
• tDCS (transcranial Direct Current Stimulation) for cognitive enhancement and mood disorders
• Modified Electroconvulsive Therapy (MECT) for severe, treatment-resistant depression
• Magnetic Seizure Therapy — newer alternative to MECT with fewer cognitive side effects

What this means for you: If you have treatment-resistant depression or OCD that hasn't responded to medication, SMHC's neuromodulation program offers advanced, evidence-based options that are not widely available elsewhere in China.

3. Psychotherapy

Comprehensive psychotherapy services across multiple modalities:

• Psychodynamic Therapy: For personality disorders, chronic relationship patterns
• Cognitive Behavioral Therapy (CBT): For depression, anxiety, OCD, insomnia
• Mindfulness-Based Therapy: For stress, relapse prevention, emotional regulation
• Family Therapy: For adolescent disorders, family system issues
• Group Therapy: For social anxiety, interpersonal skills, support

4. Rehabilitation & Recovery

Functional recovery programs including:

• Occupational Therapy: Restoring daily living skills
• Morita Therapy: Japanese-originated acceptance-based approach
• Art Therapy: Expressive therapy for trauma, emotional processing
• Music Therapy: Cognitive stimulation, emotional regulation

Specialty Areas

SMHC provides expert treatment for:

• Schizophrenia and bipolar disorder: Comprehensive medication management, psychosocial interventions, family education
• Depression and anxiety disorders: From mild to severe, including treatment-resistant cases
• Obsessive-Compulsive Disorder: Dedicated OCD center with CBT, neuromodulation, and medication
• Sleep disorders: Integrated sleep medicine approach
• Eating disorders: Multidisciplinary treatment combining medical, nutritional, and psychological care
• Geriatric cognitive impairment: Alzheimer's disease, vascular dementia, Lewy body dementia
• Child & adolescent disorders: ADHD, autism spectrum disorders, behavioral and emotional disorders
• Substance use disorders: Alcohol, tobacco, drugs, behavioral addictions
• Psychosomatic disorders: Physical symptoms with psychological origins

Distinguished Medical Team

SMHC's faculty includes China's most prominent psychiatrists:

World-Class Facilities & Equipment

In October 2025, SMHC inaugurated a 74,000 m² Clinical Diagnosis & Treatment Center for Severe Mental Disorders, integrating outpatient clinics, inpatient wards, clinical research, cognitive assessment, physical therapy, rehabilitation, and advanced imaging.

Key Equipment

• Siemens Terra X 7.0T MR — Ultra-high field MRI for research and clinical imaging
• Research-grade PRISMA 3.0T MR, VIDA 3.0T MR — Advanced neuroimaging
• Magnetoencephalography (MEG) — Functional brain mapping
• MR-guided focused ultrasound (MRgFUS) — Non-invasive brain stimulation
• High-density EEG acquisition platform — Advanced electrophysiology
• Advanced MECT and magnetic seizure therapy devices — State-of-the-art neuromodulation

What this means for you: SMHC's imaging and neuromodulation equipment is among the most advanced in Asia, enabling precise diagnosis and cutting-edge treatment for complex psychiatric and neurological conditions.

Research & Innovation

SMHC is a research powerhouse driving psychiatric innovation in China:

• National "Major New Drug Innovation" GCP Demonstration Platform
• Leading multiple Phase III clinical trials for Class 1 investigational new drugs, including:
  • GV-971 — Anti-Alzheimer's disease drug (derived from marine seaweed, China's first original Alzheimer's drug in over a decade)
• Over 20 national and provincial science & technology awards
• AI-powered mental health screening and diagnosis platform (awarded by Ministry of Industry & Information Technology)
• Publishes General Psychiatry journal in partnership with BMJ Publishing Group

Industry Leadership

SMHC leads China's psychiatric community through multiple initiatives:

• 2025: Led the establishment of the Shanghai Municipal Hospital Psychiatry Alliance (11 Grade 3A hospitals including Ruijin, Zhongshan, Huashan)
• Leads the China Psychiatric Neuromodulation Alliance
• Yangtze River Delta Integrated Mental Health Quality Control Consortium
• National TCM Psychiatry Specialty Alliance
• Operates the 12356 Shanghai Psychological Hotline — a citywide mental health crisis line

Why International Patients Choose SMHC

For international patients seeking psychiatric care, SMHC offers:

1. National leadership: #2 ranking in China with National Center for Mental Health Disorders designation
2. Comprehensive subspecialties: From OCD to Alzheimer's to child psychiatry, all major conditions are covered by dedicated experts
3. Advanced neuromodulation: rTMS, MECT, magnetic seizure therapy — options not widely available elsewhere
4. Integrated approach: Combining Western evidence-based medicine with traditional Chinese approaches
5. Research-active center: Access to clinical trials for novel treatments including GV-971 for Alzheimer's
6. World-class facilities: 74,000 m² new center with 7T MRI and advanced neuromodulation equipment
7. Shanghai location: Easy international access, cosmopolitan city with excellent infrastructure

Practical Information for International Patients

Getting there: Shanghai Pudong International Airport (PVG) and Shanghai Hongqiao International Airport (SHA) serve major cities worldwide. SMHC's Xuhui Campus is in central Shanghai, approximately 45 minutes from Pudong Airport.

Language support: The center has experience treating international patients and can arrange medical interpreters for English speakers. For other languages, advance notice is recommended.

Appointment process: International patients can request remote consultations with medical records and psychological assessments before traveling. The center's international patient office coordinates visa invitation letters, hospital appointments, and accommodation.

Treatment timeline:

• Initial assessment: 2-3 days for comprehensive psychiatric evaluation, psychological testing, and neuroimaging
• Outpatient treatment: 1-2 weeks for medication optimization, psychotherapy initiation, neuromodulation planning
• Inpatient treatment: 4-8 weeks for intensive treatment programs (severe depression, treatment-resistant OCD, etc.)
• Follow-up: Remote follow-up available, with return visits as needed

Confidentiality: SMHC adheres to strict patient confidentiality standards. International patients can request enhanced privacy protections.

Campuses

SMHC operates two campuses:

Xuhui Campus (Main Campus)
600 South Wanping Road, Shanghai 200030, China

• Outpatient services, inpatient wards, clinical psychology

Minhang Campus
3210 Humin Road, Shanghai 201108, China

• Additional inpatient capacity, research facilities

Tel: +86-21-32100600
Website: www.smhc.org.cn

---

At ChinaMed Select, we specialize in connecting international patients with China's top mental health centers. If you're considering treatment at Shanghai Mental Health Center, contact us for a free consultation and second opinion. Mental health treatment requires sensitivity and expertise — we're here to help you navigate this journey.